After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. The current market capitalization of Thermo Fisher Scientific Inc. is $227.87B. A total of 1.6 million shares were traded on the day, compared to an average of 1.72M shares.
In the most recent transaction, CASPER MARC N sold 10,000 shares of TMO for 571.08 per share on Feb 29 ’24. After the transaction, the Chairman & CEO now owns 125,816 company shares. In a previous transaction on Feb 28 ’24, CASPER MARC N sold 10,000 shares at 570.18 per share. TMO shares that Chairman & CEO owns now total 128,485.
Among the insiders who sold shares, CASPER MARC N disposed of 10,000 shares on Feb 27 ’24 at a per-share price of $564.72. This resulted in the Chairman & CEO holding 128,485 shares of TMO after the transaction. In another insider transaction, CASPER MARC N sold 5,547 shares at $550.62 per share on Feb 15 ’24. Company shares held by the Chairman & CEO now total 43,608.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Thermo Fisher Scientific Inc. pays an annual dividend of $1.40, resulting in a dividend yield of 0.23%, and it has a price to earnings (P/E) ratio of 38.68. TMO’s most recent ex-dividend date was 3/14/2024 when it declared a $0.39 quarterly dividend that was paid in cash on 4/15/2024. Previously, the company paid the dividend on 1/16/2024 with an ex-dividend date of 12/14/2023. The TMO stock dividend was $0.35 per share in cash.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TMO has a high of $598.91 and a low of $415.60.
As of this writing, TMO has an earnings estimate of $4.73 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $5 per share and a lower estimate of $4.64. The company reported an EPS of $5.69 in the last quarter, which was 1.40% higher than expectations of $5.61.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $120.87, while its Total Shareholder’s Equity was $40.98B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.39.
